ciprofloxacin has been researched along with bis(3',5')-cyclic diguanylic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Borlee, BR; Borlee, GI; Brock, MT; Fedderly, GC; Ferris, RA; Filipowska, LK; Hyatt, DR; Russell, MM | 1 |
| Biavasco, F; Carotti, E; Cedraro, N; Citterio, B; La Teana, A; Mangiaterra, G; Vaiasicca, S | 1 |
2 other study(ies) available for ciprofloxacin and bis(3',5')-cyclic diguanylic acid
| Article | Year |
|---|---|
Pseudomonas aeruginosa variants obtained from veterinary clinical samples reveal a role for cyclic di-GMP in biofilm formation and colony morphology.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Biofilms; Cats; Ciprofloxacin; Cyclic GMP; DNA Gyrase; Dogs; Drug Resistance, Bacterial; Escherichia coli Proteins; Gene Expression; Genome, Bacterial; Gentamicins; Horses; Microbial Sensitivity Tests; Mutation; Phenotype; Phosphoric Diester Hydrolases; Phosphorus-Oxygen Lyases; Pseudomonas aeruginosa | 2017 |
Contribution of Drugs Interfering with Protein and Cell Wall Synthesis to the Persistence of
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; Biofilms; Ceftazidime; Cell Wall; Ciprofloxacin; Cyclic GMP; Drug Combinations; Drug Resistance, Multiple, Bacterial; Gene Expression Regulation, Bacterial; Green Fluorescent Proteins; In Vitro Techniques; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Tobramycin; Transformation, Bacterial | 2021 |